Skip to main content
. 2009 Oct;4(10):1565–1574. doi: 10.2215/CJN.02250409

Table 2.

Characteristics of studies that analyzed the effects of surgical interventions to reduce weight on renal parameters

Reference Type of Study Baseline Kidney Disease Preintervention BMI (kg/m2) or Body Weight (kg) Comorbidities No. of Patients Intervention Follow-up Renal Outcomes Nonrenal Outcomesa
Agrawal et al. (30), 2008 Retrospective Microalbuminuria 49.1 ± 7.4 Diabetes, metabolic syndrome 94 Roux-en-Y gastric bypass 12 mo Urine albumin-creatinine ratio Hs-CRP, BP, diabetes
Alexander and Goodman et al. (31), 2007 Prospective cohort ESRD, CKD NA NA 45 (total)
23 (CKD)
22 (dialysis)
Roux-en-Y gastric bypass Up to 13 yr Serum creatinine NA
Brochner-Mortensen et al. (32), 1980 Prospective cohort Glomerular hyperfiltration 136.4 kg None 8 End-to-side jejunoileostomy 1 yr Serum creatinine, GFR (using EDTA) Extracellular volume
Chagnac et al. (29), 2003 Prospective cohort Glomerular hyperfiltration 48 ± 2.4 Hypertension 17 Gastroplasty 12 to 17 mo GFR (using inulin clearance), renal plasma flow, filtration fraction, albuminuria Oral glucose tolerance test, BP
Navarro-Diaz et al. (27), 2006b Prospective cohort Glomerular hyperfiltration 53.6 ± 9.6 CAD, hypertension 85 Gastroplasty 24 mo 24-h urinary creatinine clearance, proteinuria BP
Palomar et al. (26), 2005 Prospective cohort Microalbuminuria and overt proteinuria 46.9 ± 6.3 Hypertension, diabetes, obstructive sleep apnea 35 Biliopancreatic diversion 12 mo Proteinuria, nephrolithiasis Lipid profile, BP, hematologic parameters
Serra et al. (28), 2006b Prospective cohort Microalbuminuria 53.3 ± 9.6 Hypertension 70 Roux-en-Y gastric bypass 12 mo 24-h urinary creatinine clearance, proteinuria Leptin, adiponectin, lipid profile, insulin level, BP

CAD, coronary artery disease; hs-CRP, high-sensitivity C-reactive protein.

a

All studies measured BMI and change in weight over time.

b

Same set of patients were included and different outcome measures were reported, and only study with longer duration of follow-up was used for analysis.

HHS Vulnerability Disclosure